Issue 15, February 17, 2022
America faces daunting and complex healthcare challenges that include and go beyond the current pandemic. In myriad ways, innovative healthcare companies are developing solutions to improve access to care, battle disease, strengthen population health, and meet the needs of underserved communities. This newsletter will offer examples of Healthcare Leadership Council members answering the call.
IN THE NEWS The nomination of Dr. Califf was a prudent choice and the nation is fortunate to have someone with Dr. Califf's expertise and stellar track record of accomplishment at the helm of this vital agency.
Memory Center Receives National Healthcare Award from Health Industry Leaders
The Healthcare Leadership Council honored the Center for Comprehensive Care and Research on Memory Disorders at the University of Chicago Medicine with the Redefining American Healthcare Award in a virtual ceremony on Thursday, February 3. ON THE BLOG
This year HIMSS takes place March 14-18 in Orlando, Florida. Booth information for HLC members that will be exhibiting is listed. UPCOMING EVENTS Strengthening Affordability and Accessibility: Reimagining Healthcare Delivery
Healthcare delivery is rapidly transforming in ways that are expanding access to care, improving health outcomes, and reducing costs. Three of the nation's most respected healthcare providers will discuss how they are broadening care access points, linking quality with cost-efficiency, and elevating public health by taking a holistic approach to health and wellness.
Presentations by: SSM Health
March 2 at 2:00 p.m. ET
FOLLOW US
CONTACT US Healthcare Leadership Council 750 9th St. NW Suite 500 Washington, DC 20001
.jpg "Discovery Accelerator")
Bristol Myers Squibb Health Equity Grants Will Help Medically Underserved Patients
Bristol Myers Squibb is providing approximately $8 million in health equity grants to 24 non-profit organizations in the U.S. The grants will improve access and quality care for medically underserved patients and communities in the oncology, cardiology, immunology and hematology therapeutic areas.
The grants are part of a 5-year, $150 million investment by Bristol Myers Squibb to address health disparities, increase clinical trial diversity, expand supplier diversity, increased workforce representation, and enhance employee giving in support of social justice organizations. The new grantees include, for example, the Dia de la Mujer Latina organization that will focus on lung cancer screening, prevention and care in largely Latino communities in Houston, El Paso, Orlando, Chicago, and Los Angeles, and CommonSpirit in North Dakota which will address social determinants of health and connect rural patients and community members with housing and nutrition services.
Adam Lenkowsky, senior vice president and general manager of U.S. Cardiovacular, Immunology, and Oncology for Bristol Myers Squibb said, "We know that the complexities of specialty care bring unique challenges that community health workers and patient navigators can help solve. They are trusted members of their communities, have deep knowledge of health systems and are vital to medically underserved patients receiving high quality care, including access to medical innovations and clinical trials."
Surescripts Medication History Services Are Increasing Drug Adherence, Giving Health Providers Valuable Patient Information
Data from 2021 affirms that medication history services provided by Surescripts is enabling health providers to better utilize their time, providing them with valuable information to enhance patient care, and strengthening patient medication adherence. Last year, these Surescripts programs filled data gaps in 86 percent of medication histories, helping reduce the possibility of adverse drug events and associated readmissions. Surescripts also removed duplicate medication in 62 percent of medication histories.
At Mount Sinai Health System in New York, for example, officials worked with Surescripts to proactively notify care teams about prescription activities, including when refills are not picked up, when no refills remain, and when a new prescription is processed by a new prescriber. After just five months, Mount Sinai saw a significant increase in patient medication adherence.
Surescripts CEO Tom Skelton said, "In an environment when time with patients is a premium, these enhancements simplify collecting a patient's medication history while supplying the most robust record available. Together with our partners across the Surescripts Network Alliance, we're empowering providers by quickly supplying them with the patient information they need so they can spend their time with patients."
|
.png){kind=small}
